Related Experiment Videos
Soluble intercellular adhesion molecule-1 (sICAM-1) in atopic dermatitis
M Koide1, Y Tokura, F Furukawa
1Department of Dermatology, Hamamatsu University School of Medicine, Japan.
Journal of Dermatological Science
|October 1, 1994
Summary
Serum soluble intercellular adhesion molecule-1 (sICAM-1) levels are elevated in atopic dermatitis (AD) and eczematous dermatitis (ED). Decreased sICAM-1 correlates with improved AD activity, suggesting its use in monitoring AD progression.
Area of Science:
- Immunology
- Dermatology
- Biochemistry
Background:
- Atopic dermatitis (AD) and eczematous dermatitis (ED) are inflammatory skin conditions.
- Intercellular adhesion molecules play roles in immune responses and inflammation.
- Soluble intercellular adhesion molecule-1 (sICAM-1) is a marker of endothelial activation and inflammation.
Purpose of the Study:
- To investigate serum sICAM-1 levels in patients with AD and ED.
- To assess the correlation between sICAM-1 levels and disease activity in AD.
- To evaluate sICAM-1 as a potential biomarker for monitoring AD.
Main Methods:
- Serum sICAM-1 levels were quantified using enzyme-linked immunosorbent assay (ELISA).
- The study included 88 patients with AD, 29 with ED, and 33 healthy controls.
- Longitudinal monitoring of AD patients assessed changes in sICAM-1 with disease activity.
Main Results:
- Serum sICAM-1 levels were significantly higher in both AD and ED patients compared to healthy controls.
- A significant decrease in sICAM-1 levels was observed in AD patients as their disease activity improved.
- In AD patients, sICAM-1 levels correlated significantly with total leukocyte and lymphocyte counts.
Conclusions:
- Elevated serum sICAM-1 levels are associated with AD and ED.
- sICAM-1 may serve as a valuable immunologic marker for monitoring disease activity in atopic dermatitis.
- The correlation of sICAM-1 with leukocyte and lymphocyte counts in AD suggests its involvement in the inflammatory process.